The content on this site is intended for healthcare professionals only
Tito Fojo talks to ecancer at EAPM 2017 in Belfast.
He was asked to speak at the conference to provide an alternate and opposing view to personalised medicine.
He believes that we are not ready to start personalising lots of individual patients.
Lack of knowledge and extrapolation of data worries him, and he thinks that we could cause more damage than good if we jump the gun.
He sheds light on the amount of data lost through personalising treatments without capturing the data during the process.
The added value of integrative medicine
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Global adoption of single-shot targeted IORT for breast cancer
